Natco Pharma Ltd.
| BSE: 524816 | Sector: Health care |
| NSE: NATCOPHARM | ISIN Code: INE987B01026 |
| BSE 00:00 | 05 Mar | 832.75 |
-4.05 (-0.48%) |
OPEN
836.80 |
HIGH
852.70 |
LOW
823.95 |
| NSE 00:00 | 05 Mar | 833.80 |
-3.85 (-0.46%) |
OPEN
841.05 |
HIGH
853.00 |
LOW
823.10 |
| OPEN | 836.80 |
| PREVIOUS CLOSE | 836.80 |
| VOLUME | 18874 |
| 52-Week high | 995.05 |
| 52-Week low | 450.00 |
| P/E | 42.97 |
| Mkt Cap.(Rs cr) | 15,185 |
| Buy Price | 832.75 |
| Buy Qty | 300.00 |
| Sell Price | 850.00 |
| Sell Qty | 128.00 |
Natco Pharma Ltd. (NATCOPHARM) - Company Information
Natco Pharma Ltd
Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company's focus is primarily on niche therapeutic areas and complex products. The company sells its products in over 40 countries. FDF products are sold in the United States I...> More
| COMPANY INFORMATION | |||||||
| Chairman & Managing Director : | V C Nannapaneni | ||||||
| Independent Director : | G S Murthy | ||||||
| Vice Chairman : | Rajeev Nannapaneni | ||||||
| Company Secretary : | M Adinarayana | ||||||
| Independent Director : | T V Rao | ||||||
| Independent Director : | D G Prasad | ||||||
| Independent Director : | Leelaa Digumarti | ||||||
| Director : | PSRK Prasad | ||||||
| Independent Director : | MUR Naidu | ||||||
| Director : | D Linga Rao | ||||||
| Director : | Sridhar Sankararaman | ||||||
| AUDITOR : | B S R & Associates LLP | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs & Formln | ||||||
| HOUSE NAME : | Natco | ||||||
| Registered office | |||||||
| Natco House, Road No 2 Banjara Hills,Hyderabad,Telangana-500033 | |||||||
| Ph : 91-040-23547532 | |||||||
| WEBSITE : http://www.natcopharma.co.in | |||||||
| E-mail : investors@natcopharma.co.in | |||||||
Quick Links for Natco Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
